Immune checkpoint failures in inflammatory myopathies: An overview

Autoimmun Rev. 2018 Aug;17(8):746-754. doi: 10.1016/j.autrev.2018.01.026. Epub 2018 Jun 6.

Abstract

Dermatomyositis (DM), polymyositis (PM), inclusion body myositis (IBM), immune mediated necrotizing myopathy (IMNM) and overlap myositis (OM) are classified as inflammatory myopathies (IM) with involvement of autoimmune features such as autoreactive lymphocytes and autoantibodies. Autoimmunity can be defined as a loss in self-tolerance and attack of autoantigens by the immune system. Self-tolerance is achieved by a group of immune mechanisms occurring in central and periphal lymphoid organs and tissues, called immune checkpoints, that work in synergy to protect the body from harmful immune reactions. Autoimmune disorders appear when immune checkpoints fail. In this review, the different immune checkpoint failures are discussed in DM, PM, IBM and IMNM. Exploring research contribution in each of these immune checkpoints might help to highlight research perspectives in the field and obtain a more complete picture of IM disease pathology.

Keywords: Dermatomyositis; Immune mediated necrotizing myopathy; Immunity checkpoint failures; Inclusion body myositis; Polymyositis.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Cell Cycle Checkpoints / drug effects*
  • Humans
  • Immunotherapy*
  • Myositis / drug therapy*
  • Myositis / immunology
  • Prognosis

Substances

  • Antibodies, Monoclonal